GeneArrest Overview
- Founded
-
2009
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
GeneArrest General Information
Description
Developer of an anti-gene drug platform. The company develops a computational design of modular polymers that bind a specific sequence of DNA.
Contact Information
Website
www.genearrest.com
Formerly Known As
Antigene Biotechnologies
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- POB 1252, Nazareth Industrial Area
- NGT incubator, Sami Shahin building
- Nazareth 16000
- Israel
GeneArrest Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Apr-2018 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
GeneArrest Patents
GeneArrest Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20130231480-A1 | Sequence specific double-stranded dna/rna binding compounds and uses thereof | Abandoned | 22-Jul-2010 | 0000000000 | |
| EP-2596102-A2 | Sequence specific double-stranded dna/rna binding compounds and uses thereof | Withdrawn | 22-Jul-2010 | 0000000000 | |
| US-20100284959-A1 | Sequence specific double-stranded dna/rna binding compounds and uses thereof | Abandoned | 23-Jan-2008 | C07D473/16 |
GeneArrest Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mizied Falah Ph.D | Co-Founder & Chief Technology Officer | ||
| Anwar Rayan Ph.D | Co-Founder & Chief Executive Officer |
GeneArrest Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
